333 related articles for article (PubMed ID: 1703543)
1. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins.
Culty M; Miyake K; Kincade PW; Sikorski E; Butcher EC; Underhill C
J Cell Biol; 1990 Dec; 111(6 Pt 1):2765-74. PubMed ID: 1703543
[TBL] [Abstract][Full Text] [Related]
2. CD44-hyaluronate interaction mediates in vitro lymphocyte binding to the white matter of the central nervous system.
Aho R; Jalkanen S; Kalimo H
J Neuropathol Exp Neurol; 1994 May; 53(3):295-302. PubMed ID: 7513749
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types.
Picker LJ; Nakache M; Butcher EC
J Cell Biol; 1989 Aug; 109(2):927-37. PubMed ID: 2474557
[TBL] [Abstract][Full Text] [Related]
4. Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor.
Green SJ; Tarone G; Underhill CB
Exp Cell Res; 1988 Oct; 178(2):224-32. PubMed ID: 2458949
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition.
Zheng Z; Katoh S; He Q; Oritani K; Miyake K; Lesley J; Hyman R; Hamik A; Parkhouse RM; Farr AG; Kincade PW
J Cell Biol; 1995 Jul; 130(2):485-95. PubMed ID: 7542251
[TBL] [Abstract][Full Text] [Related]
6. CD44 is the principal cell surface receptor for hyaluronate.
Aruffo A; Stamenkovic I; Melnick M; Underhill CB; Seed B
Cell; 1990 Jun; 61(7):1303-13. PubMed ID: 1694723
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
Asplund T; Heldin P
Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.
Jalkanen S; Bargatze RF; de los Toyos J; Butcher EC
J Cell Biol; 1987 Aug; 105(2):983-90. PubMed ID: 2442176
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-CD44 monoclonal antibody on adhesion of erythroid leukemic cells (ELM-I-1) to hematopoietic supportive cells (MS-5): CD44, but not hyaluronate-mediated, cell-cell adhesion.
Sugimoto K; Tsurumaki Y; Hoshi H; Kadowaki S; LeBousse-Kerdiles MC; Smadja-Joffe F; Mori KJ
Exp Hematol; 1994 Jun; 22(6):488-94. PubMed ID: 7514542
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.
Miyake K; Underhill CB; Lesley J; Kincade PW
J Exp Med; 1990 Jul; 172(1):69-75. PubMed ID: 2193100
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes.
Asher R; Bignami A
Exp Cell Res; 1992 Nov; 203(1):80-90. PubMed ID: 1426053
[TBL] [Abstract][Full Text] [Related]
12. Binding of human leukocytes to fibronectin is augmented by an anti-CD44 mAb (TL-1) and blocked by another anti-CD44 mAb (Hermes-3) but not by anti-VLA-4/VLA-5 mAbs.
Cao L; Yoshino T; Kawasaki N; Yanai H; Kawahara K; Kondo E; Omonishi K; Takahashi K; Akagi T
Immunobiology; 1996-1997; 196(5):504-12. PubMed ID: 9145328
[TBL] [Abstract][Full Text] [Related]
13. Activation of CD44 induces ICAM-1/LFA-1-independent, Ca2+, Mg(2+)-independent adhesion pathway in lymphocyte-endothelial cell interaction.
Toyama-Sorimachi N; Miyake K; Miyasaka M
Eur J Immunol; 1993 Feb; 23(2):439-46. PubMed ID: 7679645
[TBL] [Abstract][Full Text] [Related]
14. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway.
DeGrendele HC; Estess P; Picker LJ; Siegelman MH
J Exp Med; 1996 Mar; 183(3):1119-30. PubMed ID: 8642254
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte migration into the skin: the role of lymphocyte homing receptor (CD44) and endothelial cell antigen (HECA-452).
Jalkanen S; Saari S; Kalimo H; Lammintausta K; Vainio E; Leino R; Duijvestijn AM; Kalimo K
J Invest Dermatol; 1990 Jun; 94(6):786-92. PubMed ID: 1693939
[TBL] [Abstract][Full Text] [Related]
16. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.
Culty M; Nguyen HA; Underhill CB
J Cell Biol; 1992 Feb; 116(4):1055-62. PubMed ID: 1370836
[TBL] [Abstract][Full Text] [Related]
17. The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate.
Wu L; Kincade PW; Shortman K
Immunol Lett; 1993 Sep; 38(1):69-75. PubMed ID: 7507884
[TBL] [Abstract][Full Text] [Related]
18. Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor.
Pals ST; Hogervorst F; Keizer GD; Thepen T; Horst E; Figdor CC
J Immunol; 1989 Aug; 143(3):851-7. PubMed ID: 2663988
[TBL] [Abstract][Full Text] [Related]
19. CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen.
Ishii S; Ford R; Thomas P; Nachman A; Steele G; Jessup JM
Surg Oncol; 1993 Aug; 2(4):255-64. PubMed ID: 7504563
[TBL] [Abstract][Full Text] [Related]
20. The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity.
Underhill CB; Green SJ; Comoglio PM; Tarone G
J Biol Chem; 1987 Sep; 262(27):13142-6. PubMed ID: 2443488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
